Short Peripheral Intravenous Catheters Sales Market Outlook

The global short peripheral intravenous catheters market is projected to reach approximately USD 3.5 billion by 2035, growing at a robust compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2035. The increasing demand for safe and efficient intravenous therapies, coupled with the rising prevalence of chronic diseases and the need for frequent medication administration, is driving this market's expansion. Moreover, technological advancements in catheter design and safety features are fostering innovation, thereby enhancing patient care and reducing healthcare-associated infections. Additionally, the growing awareness of infection control practices among healthcare professionals is propelling market growth, as patients increasingly seek reliable intravenous solutions across various healthcare settings.

Growth Factor of the Market

One of the primary growth factors for the short peripheral intravenous catheters market is the increasing prevalence of chronic diseases that require continuous medication administration, such as diabetes, cancer, and cardiovascular disorders. As these diseases become more common, healthcare providers are compelled to seek reliable and effective intravenous solutions to ensure optimal patient outcomes. Furthermore, the rising elderly population, who often suffer from multiple comorbidities requiring frequent medical treatments, is significantly influencing market dynamics. Another critical factor is the advancements in catheter technology. Innovations like safety-engineered catheters that minimize the risk of needlestick injuries and infection are gaining traction among healthcare providers. Additionally, the shift toward outpatient and homecare services is reshaping the landscape, as patients increasingly prefer receiving care in more comfortable settings. Lastly, the heightened focus on infection control and prevention in healthcare facilities has led to the adoption of more sophisticated IV catheter designs, further driving market growth.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 6.5% during the forecast period from 2025 to 2035.
• Technological advancements in catheter designs are enhancing safety and efficacy.
• The growing prevalence of chronic diseases is a significant driver for market growth.
• Increased focus on infection control practices is influencing catheter adoption.
• Shifts toward outpatient and homecare services are reshaping the market landscape.

By Product Type

Integrated Catheters:

Integrated catheters are designed to enhance the safety and efficacy of intravenous therapy by incorporating features such as built-in safety mechanisms that help prevent needlestick injuries. These catheters are often pre-packaged with needle safety devices, which significantly reduce the risk associated with traditional IV setups. The demand for integrated catheters is rising due to an increasing awareness of occupational hazards among healthcare workers and enhanced regulatory standards aimed at improving patient safety. The convenience of ready-to-use integrated devices appeals to healthcare settings looking to optimize workflows and minimize the time spent on catheter preparation. As such, integrated catheters are increasingly becoming the preferred choice in hospitals and clinics, where safety and efficiency are paramount in patient care.

Non-integrated Catheters:

Non-integrated catheters are traditional catheter models that do not come with built-in safety features. Despite this, they remain widely used due to their cost-effectiveness and versatility in various medical applications. These catheters are typically selected for short-term use in stable patients, particularly in ambulatory surgical centers and clinics where infection risk is lower and routine monitoring is feasible. Their straightforward design allows healthcare providers to customize their setups according to specific patient requirements, making them an enduring choice in many medical environments. However, amid increasing safety concerns associated with non-integrated models, the market for these products is gradually shifting toward more advanced designs.

Winged Catheters:

Winged catheters, commonly referred to as "butterfly" needles, are designed with flexible "wings" that facilitate better grip during insertion. Known for their ease of use and precision, winged catheters are predominantly employed for venipuncture in pediatric and geriatric patients. Their design minimizes discomfort and allows for better control during insertion, making them an excellent choice for short-term intravenous access. As the geriatric population continues to grow, the demand for winged catheters is projected to rise, especially in outpatient settings and home care. The increasing preference for minimally invasive procedures is further bolstering the use of this catheter type, making it a critical segment within the overall market.

Ported Catheters:

Ported catheters offer a unique design that allows for multiple accesses through a single insertion site, making them particularly useful for patients requiring frequent blood draws or medication administration. This feature minimizes the need for multiple venipunctures, reducing patient discomfort and the risk of complications such as phlebitis. Ported catheters are commonly used in oncology and chronic disease management, where patients may receive continuous treatment over an extended period. The convenience and efficiency of ported catheters are driving their increased adoption among healthcare providers, contributing significantly to the overall market growth.

Safety Catheters:

Safety catheters are specifically engineered to minimize the risk of needlestick injuries, a critical concern in healthcare settings. These catheters come equipped with safety mechanisms that automatically retract or cover the needle after use, safeguarding healthcare workers and patients alike. The heightened emphasis on safety and infection control practices in hospitals and clinics is propelling the adoption of safety catheters, making them a preferred choice for intravenous therapy. With ongoing regulatory requirements mandating safer medical devices, the market for safety catheters is expected to witness substantial growth, reflecting the healthcare industry's commitment to patient and worker safety.

By Application

Hospitals:

Hospitals are the largest segment for short peripheral intravenous catheters, driven by the high patient turnover and the need for various intravenous therapies ranging from hydration to medication administration. The complex healthcare environment necessitates the use of various catheter types to cater to different medical needs, including emergency care, surgical procedures, and critical care. Hospitals prioritize patient safety, leading to increased adoption of integrated and safety catheters to minimize infection risks and improve patient outcomes. The ongoing advancements in catheter technology are particularly influential in hospital settings, where efficiency and effectiveness are crucial to managing patient care.

Clinics:

Clinics represent a growing application segment for short peripheral intravenous catheters due to rising outpatient procedures and the increased focus on providing care in more accessible settings. Clinics often require flexible intravenous solutions for a variety of uses, including medication administration, hydration, and blood draws. The demand for cost-effective and versatile catheter options is particularly strong in clinics, where healthcare providers seek to balance quality care with affordability. The preference for non-integrated and winged catheters is prevalent in these environments, reflecting the need for efficiency in procedures that may not require extensive intravenous therapy.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly utilizing short peripheral intravenous catheters for outpatient procedures that necessitate anesthesia or sedation. The rise in minimally invasive surgeries and outpatient care models has propelled the demand for reliable and effective IV access solutions. These centers benefit from the use of integrated and safety catheters that ensure a streamlined workflow while minimizing complications associated with intravenous therapy. As the trend toward outpatient surgeries continues to grow, ASCs are expected to play a significant role in driving the adoption of advanced catheter technologies, shaping the future of the market.

Homecare Settings:

Homecare settings are emerging as a crucial application segment for short peripheral intravenous catheters, driven by the increasing prevalence of chronic diseases and the aging population. Patients requiring ongoing treatment can receive care in the comfort of their homes, reducing the burden on healthcare facilities while enhancing patient quality of life. Safety and ease of use are paramount in homecare settings, leading to the adoption of integrated and safety catheters that allow caregivers to manage intravenous therapies effectively. As the healthcare industry shifts towards patient-centered care, the homecare segment is poised to grow significantly, opening up new opportunities for catheter manufacturers.

Others:

This segment encompasses various applications, including specialized clinics and rehabilitation centers that require short peripheral intravenous catheters for a diverse range of medical procedures. The demand for catheters in these settings is often driven by specific treatments that require intravenous access, such as infusions for nutritional therapy or pain management. The variety of catheter options available allows healthcare providers to choose the most suitable devices for their unique patient populations, promoting flexibility in treatment delivery. As healthcare practices continue to evolve, this segment is likely to expand, highlighting the versatility of short peripheral intravenous catheters across diverse medical applications.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel for short peripheral intravenous catheters, particularly for manufacturers looking to establish strong relationships with healthcare providers. This channel allows companies to offer comprehensive support, education, and service directly to hospitals and clinics, enhancing customer satisfaction and loyalty. Direct sales also enable manufacturers to quickly respond to market demands and customize their offerings based on specific customer needs. As the focus on patient safety and quality care intensifies, manufacturers leveraging direct sales are likely to gain a competitive advantage by ensuring their products meet the highest standards.

Distributor Sales:

Distributor sales play an essential role in the short peripheral intravenous catheters market, as they facilitate the widespread availability of products across various healthcare settings. Distributors often have established relationships with healthcare facilities, allowing them to reach a broader customer base and efficiently manage inventory. This channel also enables manufacturers to focus on production and innovation while relying on distributors to handle logistics and sales. As the market continues to grow, distributor partnerships will remain vital, ensuring that healthcare providers have access to the latest catheter technologies and innovations when needed.

By Material Type

Polyurethane:

Polyurethane is a widely used material for short peripheral intravenous catheters due to its excellent biocompatibility and flexibility. Catheters made from polyurethane often exhibit resistance to kinking and blocking, ensuring reliable performance during intravenous therapy. The material's inherent strength and durability make it suitable for various medical applications, particularly in high-flow situations. Additionally, the low friction coefficient of polyurethane reduces the risk of phlebitis, making it an attractive option for healthcare providers concerned about patient safety. As demand for long-lasting and efficient catheters increases, polyurethane-based options are expected to see continued growth within the market.

Teflon:

Teflon catheters are notable for their smooth surface, which facilitates easy insertion and minimizes irritation to the blood vessel. This material is particularly popular for short-term applications, where quick access is essential. Teflon's biocompatibility ensures minimal adverse reactions in patients, making it a trusted choice among healthcare providers. Furthermore, the ability of Teflon catheters to resist chemical degradation makes them suitable for various intravenous therapies. As healthcare facilities seek to enhance patient comfort and reduce complications, the Teflon segment of the market is anticipated to expand, driven by its unique properties and advantages.

Silicone:

Silicone catheters are increasingly favored for their flexibility, biocompatibility, and resistance to kinking and occlusion. These properties make silicone catheters ideal for long-term use, especially in patients requiring repeated access for blood draws or drug administration. The material's softness and smoothness contribute to patient comfort, reducing discomfort during insertion and minimizing the risk of phlebitis. Silicone's ability to maintain performance over extended periods is also a significant advantage, making it a popular choice in various healthcare settings. As healthcare providers prioritize patient-centered care, the silicone catheter segment is expected to witness robust growth, highlighting its relevance in the overall market.

Others:

The "others" category encompasses various materials used in catheter manufacturing, which may include specialty polymers and hybrid materials designed to optimize performance and safety. These materials often provide unique benefits, catering to specific clinical needs or applications. As technology advances, the development of innovative catheter materials may lead to improved safety profiles, enhanced durability, and better patient outcomes. The presence of diverse material options allows healthcare providers to select devices that best align with their specific requirements, fostering a dynamic and competitive market landscape.

By Region

The North American region currently dominates the short peripheral intravenous catheters market, accounting for a significant portion of the global revenue. The advanced healthcare infrastructure, coupled with high healthcare spending and a growing emphasis on patient safety, contributes to the strong market presence in this region. Furthermore, awareness regarding advanced catheter technologies and the increasing prevalence of chronic diseases are bolstering demand. The North American market is anticipated to grow at a CAGR of 7% during the forecast period, driven by continuous innovations in catheter design and the adoption of safety-engineered devices. Major healthcare institutions in the region are increasingly adopting these technologies to enhance patient care and reduce complications.

In Europe, the short peripheral intravenous catheters market is also experiencing growth, propelled by the rising demand for advanced medical devices and an increasing focus on infection control practices. The European market is characterized by a trend towards standardizing safety protocols across healthcare facilities, thereby promoting the adoption of safety catheters. Moreover, the aging population and the increasing incidence of chronic diseases are driving the need for reliable intravenous solutions. The European market is expected to witness steady growth, with an estimated CAGR of 5.5% over the forecast period, reflecting the region's commitment to improving healthcare delivery and patient safety.

Opportunities

The market for short peripheral intravenous catheters presents numerous opportunities, particularly as healthcare providers increasingly prioritize patient safety and comfort. The growing focus on reducing healthcare-associated infections and enhancing patient outcomes has led to a surge in demand for advanced catheter technologies. This presents manufacturers with opportunities to innovate and develop safer, more efficient catheter designs that meet the evolving needs of healthcare providers. Additionally, with the shift towards outpatient care and home health services, there is a significant opportunity for manufacturers to cater to this growing segment with products specifically designed for use in home settings. As patients seek to receive care in more comfortable and familiar environments, investments in homecare-compatible catheter solutions can unlock new revenue streams for companies in the market.

Another promising opportunity lies in the development of innovative products that incorporate digital health solutions, such as smart catheters equipped with sensors to monitor patient conditions in real time. These advancements can significantly improve patient management and provide healthcare providers with valuable data to enhance treatment plans. Furthermore, emerging markets in Asia Pacific and Latin America are witnessing rapid healthcare advancements, creating a considerable demand for high-quality intravenous solutions. Companies that can successfully penetrate these markets with tailored products and competitive pricing strategies stand to gain substantial market share, fostering growth and diversification in their operations.

Threats

Despite the promising growth prospects, the short peripheral intravenous catheters market faces several threats that could hinder its progress. One of the most significant challenges is the intense competition among manufacturers, leading to price wars that can compress profit margins. This competitive landscape necessitates continuous innovation and differentiation to maintain market share, which can strain resources for smaller companies. Additionally, regulatory challenges and stringent compliance requirements can pose barriers to entry for new players, limiting their ability to compete effectively in the market. The potential for product recalls due to safety or quality issues can also damage a company's reputation and erode customer trust, further complicating the competitive environment.

Another critical threat stems from the increasing adoption of alternative access technologies, such as midline catheters and peripherally inserted central catheters (PICCs), which may reduce the demand for traditional short peripheral intravenous catheters in certain applications. As healthcare providers evaluate the most effective and efficient methods for delivering intravenous therapies, there is a risk that traditional catheters may be sidelined in favor of newer alternatives. This shift could result in declining sales and market share for established catheter manufacturers unless they adapt to changing market dynamics and invest in innovation.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Smiths Medical
• Terumo Corporation
• AngioDynamics, Inc.
• Vygon S.A.
• Teleflex Incorporated
• Fresenius Kabi AG
• Boston Scientific Corporation
• AccuVein, Inc.
• 3M Company
• Cardinal Health, Inc.
• IV Solutions, Inc.
• Halyard Health, Inc.
• JMS Co., Ltd.

The competitive landscape of the short peripheral intravenous catheters market is characterized by a diverse array of manufacturers, each vying for market share through innovation and strategic partnerships. Leading companies are investing heavily in research and development to create advanced catheter technologies that enhance patient safety and treatment efficacy. Collaborations between manufacturers and healthcare providers are also becoming increasingly common, allowing companies to gain valuable insights into market needs and tailor their products accordingly. As the market evolves, companies that can quickly adapt to industry changes, such as shifting healthcare regulations and changing patient demographics, are likely to emerge as frontrunners in this competitive landscape.

BD (Becton, Dickinson and Company) remains a dominant player in the market, known for its extensive range of catheter products designed to improve patient outcomes. The company emphasizes innovation, actively investing in research to develop advanced catheter technologies that minimize infection risks. Medtronic plc is another key competitor, leveraging its expertise in medical devices to offer high-quality peripheral catheters. The company's commitment to safety and efficacy has positioned it favorably in the market. Likewise, Smiths Medical has carved a niche by focusing on specialized catheters that cater to the unique needs of various medical applications, ensuring strong customer loyalty and satisfaction.

Newer entrants and established companies alike face the challenge of differentiating their products in a crowded marketplace. Companies such as Teleflex Incorporated and Fresenius Kabi AG are focusing on safety-engineered catheters and innovative designs that meet the growing demand for infection control. As competition intensifies, companies are also exploring emerging markets in Asia Pacific and Latin America, where increasing healthcare expenditures and a rising patient population offer substantial growth potential. By targeting these regions with tailored products and effective go-to-market strategies, manufacturers can position themselves for long-term success in the evolving landscape of the short peripheral intravenous catheters market.